J&J Targets Disease Management, Touts “Enlightened Decentralization”

Johnson & Johnson is moving toward a business model focused on offering "product solutions" for the healthcare system, Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia